Pages that link to "Q35231868"

The following pages link to Neuregulin-1β for the treatment of systolic heart failure (Q35231868):

Displaying 22 items.

• Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies (Q26746907) (← links)
• Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation. (Q30384457) (← links)
• Activation of EGFR/ERBB2 via pathways involving ERK1/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury (Q34312113) (← links)
• Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction (Q34598168) (← links)
• Platelet endothelial cell adhesion molecule-1 mediates endothelial-cardiomyocyte communication and regulates cardiac function. (Q35088053) (← links)
• The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation (Q36042588) (← links)
• Cardiac side effects of anticancer treatments: new mechanistic insights (Q36957758) (← links)
• An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential. (Q37121891) (← links)
• Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats (Q37288691) (← links)
• Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice (Q37686822) (← links)
• Novel biomarkers in chronic heart failure (Q37997237) (← links)
• Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function (Q38025012) (← links)
• Novel drug targets in clinical development for heart failure. (Q38202895) (← links)
• Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014). (Q38546917) (← links)
• New Targets in the Drug Treatment of Heart Failure (Q38667210) (← links)
• The Src homology and collagen A (ShcA) adaptor protein is required for the spatial organization of the costamere/Z-disk network during heart development (Q41863155) (← links)
• Transient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa). (Q47719721) (← links)
• ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation (Q50992137) (← links)
• Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes. (Q53193638) (← links)
• Breast cancer treatment and adverse cardiac events: what are the molecular mechanisms?. (Q54489633) (← links)
• Neuregulin in Health and Disease (Q63741925) (← links)
• Where are the new drugs to treat heart failure? Introduction to the special issue on “Key signaling molecules in hypertrophy and heart failure” (Q84788582) (← links)